Delivery Order SPE2DB22D1202-SPE2DB25FVFH4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $3,862.11. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vivitrol 380 mg vial-diluents, a medication commonly used in opioid addiction treatment programs. This firm fixed-price delivery order, valued at $1,001.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.51 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a $10,234.10 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, a medication used primarily for opioid use disorder treatment. This firm fixed-price contract, with a completion date of July 30, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 380 mg vials of Vivitrol, a medication used to treat opioid dependence. The contract is a firm-fixed price delivery order with a ceiling value of $16,058.67 and a performance period ending on September 5, 2024. AmerisourceBergen has been awarded multiple indefinite-delivery contracts (IDCs) with the DLA and other federal agencies to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,589.11 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565057997 Vivitrol 380 mg vials and diluents. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vivitrol, a 380 mg injectable medication, with a ceiling value of $2,002.34 and a performance period extending through May 1, 2025. The award is not associated with a set-aside program and is considered an open competition contract. AmerisourceBergen Drug Corp, headquartered in...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFH4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $6,007.02. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and is classified as a delivery order, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, and specialized medications to military healthcare systems globally. Vivitrol, an opioid antagonist medication used for alcohol and opioid use disorder treatment, represents part of the company's extensive portfolio of specialty pharmaceuticals delivered through the Defense Logistics Agency's medical supply chain to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/23/25 |